After 7-Year Product Performance Report

Boston Scientific Defibrillators vs. the Competition

Boston Scientific CRT-Ds with EnduraLife Battery Technology demonstrated 87.2% survival probability at seven years 1-4 per PPR summary.

The COGNIS Report

The Concerto Report

The Consulta Report

The Promote Report

PPR Summary Data
  

STAY UP TO DATE


Sign up to receive periodic emails about device longevity and how it impacts
patients, payers and the healthcare system.

Top